The most recent editions of all USP 2025 monographs and general chapters (United States Pharmacopeia 48–NF 43) are included in this page. PharmTech: USP Announces Monograph Revisions List and Postponed Publication of General Chapter <1226> USP Announces Monograph Revisions List and Postponed Publication of General Chapter <1226> On , an Appeals Panel of the United States Pharmacopeial Convention (“USP”) granted appeals to revisions of two compounding standards—General Chapter <795> Pharmaceutical Compounding – ... The United States Pharmacopoeia (USP) General Chapters - Packaging and Distribution Expert Committee has now proposed a new chapter to address the qualification of plastic components used in the ...

Understanding the Context

Refeyn, the company behind pioneering mass photometry technology, announces that mass photometry has been recognized by the U.S. Pharmacopeia (USP)—and referenced in the new draft USP general chapter ... When many long-term care providers first hear about USP General Chapter <800> Hazardous Drugs–Handling in Healthcare Settings (“USP 800”), they naturally confuse it with the final EPA hazardous ... The major revisions to USP General Chapters 41 and 1251 (official since 2013−2014) had implications on the quality management of balances in the laboratory.

Key Insights

The aim was to clarify and simplify ... Refeyn, the company behind pioneering mass photometry technology, announces that mass photometry has been recognized by the US Pharmacopoeia (USP)—and referenced in the new draft USP general chapter ... JD Supra: Status of USP Chapter 800 Becomes More (and Less) Clear Following USP Appeals Panel Decision Status of USP Chapter 800 Becomes More (and Less) Clear Following USP Appeals Panel Decision The United States Pharmacopoeia (USP) has released a new draft chapter proposing a set of analytical procedures and best practices to accelerate product development and support quality assessments for ...